{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:02:33Z","timestamp":1784952153836,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11060-020-03537-1","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:06:57Z","timestamp":1589807217000},"page":"367-375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8009-6430","authenticated-orcid":false,"given":"Gautam U.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan M.","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Y.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab Y.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"DeMonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"3537_CR1","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/lary.25465","volume":"125","author":"R Dutta","year":"2015","unstructured":"Dutta R, Dubal PM, Svider PF et al (2015) Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope 125:2491\u20132497. https:\/\/doi.org\/10.1002\/lary.25465","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"3537_CR2","doi-asserted-by":"publisher","first-page":"E2259","DOI":"10.1002\/hed.24152","volume":"38","author":"D Bell","year":"2016","unstructured":"Bell D, Hanna EY, Weber RS et al (2016) Neuroendocrine neoplasms of the sinonasal region. Head Neck 38(Suppl 1):E2259\u2013E2266. https:\/\/doi.org\/10.1002\/hed.24152","journal-title":"Head Neck"},{"key":"3537_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/hed.24822","volume":"39","author":"SY Su","year":"2017","unstructured":"Su SY, Bell D, Ferrarotto R et al (2017) Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck 39:1671\u20131679. https:\/\/doi.org\/10.1002\/hed.24822","journal-title":"Head Neck"},{"key":"3537_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/lary.26194","volume":"127","author":"AH Elkhatib","year":"2017","unstructured":"Elkhatib AH, Soldatova L, Carrau RL et al (2017) Role of 18F-FDG PET\/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. Laryngoscope 127:321\u2013324. https:\/\/doi.org\/10.1002\/lary.26194","journal-title":"Laryngoscope"},{"key":"3537_CR5","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.3171\/foc.2002.12.5.4","volume":"12","author":"ZR Cohen","year":"2002","unstructured":"Cohen ZR, Marmor E, Fuller GN, DeMonte F (2002) Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus 12:e3. https:\/\/doi.org\/10.3171\/foc.2002.12.5.4","journal-title":"Neurosurg Focus"},{"key":"3537_CR6","doi-asserted-by":"publisher","first-page":"52584","DOI":"10.18632\/oncotarget.9683","volume":"7","author":"P Czapiewski","year":"2016","unstructured":"Czapiewski P, Kunc M, Haybaeck J (2016) Genetic and molecular alterations in olfactory neuroblastoma\u2014implications for pathogenesis, prognosis and treatment. Oncotarget 7:52584\u201352596. https:\/\/doi.org\/10.18632\/oncotarget.9683","journal-title":"Oncotarget"},{"key":"3537_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00401-018-1854-7","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Engel NW, Stichel D et al (2018) DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol 136:255\u2013271. https:\/\/doi.org\/10.1007\/s00401-018-1854-7","journal-title":"Acta Neuropathol"},{"key":"3537_CR8","first-page":"24","volume-title":"Special tumors of the head and neck","author":"VJ Hyams","year":"1982","unstructured":"Hyams VJ (1982) Olfactory neuroblastoma (Case 6). In: Batsakis J, Hyams V, Morales A (eds) Special tumors of the head and neck. ASCP Press, Chicago, pp 24\u201329"},{"key":"3537_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0032-1321512","volume":"73","author":"JJ Van Gompel","year":"2012","unstructured":"Van Gompel JJ, Giannini C, Olsen KD et al (2012) Long-term outcome of esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surgery B 73:331\u2013336. https:\/\/doi.org\/10.1055\/s-0032-1321512","journal-title":"J Neurol Surgery B"},{"key":"3537_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12105-014-0547-3","volume":"9","author":"D Bell","year":"2015","unstructured":"Bell D, Saade R, Roberts D et al (2015) Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 9:51\u201359. https:\/\/doi.org\/10.1007\/s12105-014-0547-3","journal-title":"Head Neck Pathol"},{"key":"3537_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3%3c1571::aid-cncr2820370347%3e3.0.co;2-l","volume":"37","author":"S Kadish","year":"1976","unstructured":"Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571\u20131576. https:\/\/doi.org\/10.1002\/1097-0142(197603)37:3%3c1571:aid-cncr2820370347%3e3.0.co;2-l","journal-title":"Cancer"},{"key":"3537_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","volume":"32","author":"A Morita","year":"1993","unstructured":"Morita A, Ebersold MJ, Olsen KD et al (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32:706\u2013714. https:\/\/doi.org\/10.1227\/00006123-199305000-00002 (discussion 714\u2013715)","journal-title":"Neurosurgery"},{"key":"3537_CR13","volume-title":"Pocket guide to tnm staging of head and neck cancer and neck dissection calssification","author":"DG Deschler","year":"2008","unstructured":"Deschler DG, Day T (2008) Pocket guide to tnm staging of head and neck cancer and neck dissection calssification, 3rd edn. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria","edition":"3"},{"key":"3537_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1470-2045(01)00558-7","volume":"2","author":"P Dulguerov","year":"2001","unstructured":"Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2:683\u2013690. https:\/\/doi.org\/10.1016\/S1470-2045(01)00558-7","journal-title":"Lancet Oncol"},{"key":"3537_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/0002-9610(63)90387-8","volume":"106","author":"AS Ketcham","year":"1963","unstructured":"Ketcham AS, Wilkins RH, Van Buren JM, Smith RR (1963) A combined intracranial facial approach to the paranasal sinuses. Am J Surg 106:698\u2013703. https:\/\/doi.org\/10.1016\/0002-9610(63)90387-8","journal-title":"Am J Surg"},{"key":"3537_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0032-1311754","volume":"73","author":"SG Patel","year":"2012","unstructured":"Patel SG, Singh B, Stambuk HE et al (2012) Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B 73:208\u2013220. https:\/\/doi.org\/10.1055\/s-0032-1311754","journal-title":"J Neurol Surg B"},{"key":"3537_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00701-017-3437-0","volume":"160","author":"GU Mehta","year":"2018","unstructured":"Mehta GU, Hanna EY, DeMonte F, Raza SM (2018) Endoscopic endonasal resection of sinonasal\/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien) 160:361\u2013366. https:\/\/doi.org\/10.1007\/s00701-017-3437-0","journal-title":"Acta Neurochir (Wien)"},{"key":"3537_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archoto.2009.173","volume":"135","author":"E Hanna","year":"2009","unstructured":"Hanna E, DeMonte F, Ibrahim S et al (2009) Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol-Head Neck Surg 135:1219\u20131224. https:\/\/doi.org\/10.1001\/archoto.2009.173","journal-title":"Arch Otolaryngol-Head Neck Surg"},{"key":"3537_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1227\/01.neu.0000306095.53388.f1","volume":"61","author":"I Feiz-Erfan","year":"2007","unstructured":"Feiz-Erfan I, Suki D, Hanna E, DeMonte F (2007) Prognostic significance of transdural invasion of cranial base malignancies in patients undergoing craniofacial resection. Neurosurgery 61:1178\u20131185. https:\/\/doi.org\/10.1227\/01.neu.0000306095.53388.f1 (discussion 1185)","journal-title":"Neurosurgery"},{"key":"3537_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/lary.26908","volume":"128","author":"AC Mays","year":"2018","unstructured":"Mays AC, Bell D, Ferrarotto R et al (2018) Early stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128:1274\u20131280. https:\/\/doi.org\/10.1002\/lary.26908","journal-title":"Laryngoscope"},{"key":"3537_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/hed.23327","volume":"36","author":"TJ Ow","year":"2014","unstructured":"Ow TJ, Hanna EY, Roberts DB et al (2014) Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck 36:524\u2013530. https:\/\/doi.org\/10.1002\/hed.23327","journal-title":"Head Neck"},{"key":"3537_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.prro.2015.10.023","volume":"6","author":"W Jiang","year":"2017","unstructured":"Jiang W, Mohamed ASR, Fuller CD et al (2017) The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6:241\u2013247. https:\/\/doi.org\/10.1016\/j.prro.2015.10.023","journal-title":"Pract Radiat Oncol"},{"key":"3537_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00006123-199805000-00045","volume":"42","author":"RS Polin","year":"1998","unstructured":"Polin RS, Sheehan JP, Chenelle AG et al (1998) The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: The University of Virginia experience. Neurosurgery 42:1029\u20131037. https:\/\/doi.org\/10.1097\/00006123-199805000-00045","journal-title":"Neurosurgery"},{"key":"3537_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/pbc.25817","volume":"63","author":"R Venkatramani","year":"2016","unstructured":"Venkatramani R, Pan H, Furman WL et al (2016) Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer 63:465\u2013470. https:\/\/doi.org\/10.1002\/pbc.25817","journal-title":"Pediatr Blood Cancer"},{"key":"3537_CR25","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1200\/JCO.2010.30.9278","volume":"29","author":"S Sohrabi","year":"2011","unstructured":"Sohrabi S, Drabick JJ, Crist H et al (2011) Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol 29:e358\u2013e361. https:\/\/doi.org\/10.1200\/JCO.2010.30.9278","journal-title":"J Clin Oncol"},{"key":"3537_CR26","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/cncr.20648","volume":"101","author":"DW Kim","year":"2004","unstructured":"Kim DW, Jo YH, Jee HK et al (2004) Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 101:2257\u20132260. https:\/\/doi.org\/10.1002\/cncr.20648","journal-title":"Cancer"},{"key":"3537_CR27","doi-asserted-by":"publisher","first-page":"e3536","DOI":"10.1097\/MD.0000000000003536","volume":"95","author":"L Wang","year":"2016","unstructured":"Wang L, Ding Y, Wei L et al (2016) Recurrent olfactory neuroblastoma treated with cetuximab and sunitinib a case report. Medicine (United States) 95:e3536. https:\/\/doi.org\/10.1097\/MD.0000000000003536","journal-title":"Medicine (United States)"},{"key":"3537_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-009-0027-x","volume":"97","author":"M Preusser","year":"2010","unstructured":"Preusser M, Hutterer M, Sohm M et al (2010) Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate. J Neurooncol 97:305\u2013308. https:\/\/doi.org\/10.1007\/s11060-009-0027-x","journal-title":"J Neurooncol"},{"key":"3537_CR29","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.wneu.2019.11.112","volume":"135","author":"NR London","year":"2020","unstructured":"London NR, Rooper LM, Bishop JA et al (2020) Expression of programmed cell death ligand 1 and associated lymphocyte infiltration in olfactory neuroblastoma. World Neurosurg 135:e187\u2013e193. https:\/\/doi.org\/10.1016\/j.wneu.2019.11.112","journal-title":"World Neurosurg"},{"key":"3537_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2016.10.002","volume":"63","author":"TP van der Laan","year":"2016","unstructured":"van der Laan TP, Iepsma R, Witjes MJH et al (2016) Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. Oral Oncol 63:1\u20139. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.10.002","journal-title":"Oral Oncol"},{"key":"3537_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/hed.21940","volume":"34","author":"EH Mitchell","year":"2012","unstructured":"Mitchell EH, Diaz A, Yilmaz T et al (2012) Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck 34:1372\u20131376. https:\/\/doi.org\/10.1002\/hed.21940","journal-title":"Head Neck"},{"key":"3537_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.oraloncology.2017.09.010","volume":"74","author":"M Turri-Zanoni","year":"2017","unstructured":"Turri-Zanoni M, Maragliano R, Battaglia P et al (2017) The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol 74:21\u201329. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.09.010","journal-title":"Oral Oncol"},{"key":"3537_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.oraloncology.2006.01.002","volume":"42","author":"A Ferlito","year":"2006","unstructured":"Ferlito A, Devaney KO, Rinaldo A (2006) Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol 42:770\u2013788. https:\/\/doi.org\/10.1016\/j.oraloncology.2006.01.002","journal-title":"Oral Oncol"},{"key":"3537_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-3284-3-32","volume":"3","author":"A Likhacheva","year":"2011","unstructured":"Likhacheva A, Rosenthal D, Hanna E et al (2011) Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol 3:1\u20136. https:\/\/doi.org\/10.1186\/1758-3284-3-32","journal-title":"Head Neck Oncol"},{"key":"3537_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2%3c227::aid-cncr2820680202%3e3.0.co;2-i","volume":"68","author":"CG Moertel","year":"1991","unstructured":"Moertel CG, Kvols LK, O\u2019Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227\u2013232. https:\/\/doi.org\/10.1002\/1097-0142(19910715)68:2%3c227:aid-cncr2820680202%3e3.0.co;2-i","journal-title":"Cancer"},{"key":"3537_CR36","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/cncr.10537","volume":"94","author":"MM Fitzek","year":"2002","unstructured":"Fitzek MM, Thornton AF, Varvares M et al (2002) Neuroendocrine tumors of the sinonasal tract: results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 94:2623\u20132634. https:\/\/doi.org\/10.1002\/cncr.10537","journal-title":"Cancer"},{"key":"3537_CR37","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/lary.23463","volume":"122","author":"D Fried","year":"2012","unstructured":"Fried D, Zanation AM, Huang B et al (2012) Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation. Laryngoscope 122:2210\u20132215. https:\/\/doi.org\/10.1002\/lary.23463","journal-title":"Laryngoscope"},{"key":"3537_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hed.20748","volume":"30","author":"ED Tanzler","year":"2008","unstructured":"Tanzler ED, Morris CG, Orlando CA et al (2008) Management of sinonasal undifferentiated carcinoma. Head Neck 30:595\u2013599. https:\/\/doi.org\/10.1002\/hed.20748","journal-title":"Head Neck"},{"key":"3537_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.coc.0000189691.04140.02","volume":"29","author":"WM Mendenhall","year":"2006","unstructured":"Mendenhall WM, Mendenhall CM, Riggs CE et al (2006) Sinonasal undifferentiated carcinoma. Am J Clin Oncol Cancer Clin Trials 29:27\u201331. https:\/\/doi.org\/10.1097\/01.coc.0000189691.04140.02","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"3537_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/00005537-200208000-00023","volume":"112","author":"PY Musy","year":"2002","unstructured":"Musy PY, Reibel JF, Levine PA (2002) Sinonasal undifferentiated carcinoma; the search for a better outcome. Laryngoscope 112:1450\u20131455. https:\/\/doi.org\/10.1097\/00005537-200208000-00023","journal-title":"Laryngoscope"},{"key":"3537_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hed.10396","volume":"26","author":"D Rischin","year":"2004","unstructured":"Rischin D, Porceddu S, Peters L et al (2004) Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 26:435\u2013441. https:\/\/doi.org\/10.1002\/hed.10396","journal-title":"Head Neck"},{"key":"3537_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1200\/JCO.18.00353","volume":"37","author":"M Amit","year":"2019","unstructured":"Amit M, Abdelmeguid AS, Watcherporn T et al (2019) Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma. J Clin Oncol 37:504\u2013512. https:\/\/doi.org\/10.1200\/JCO.18.00353","journal-title":"J Clin Oncol"},{"key":"3537_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00405-012-2008-5","volume":"270","author":"A Al-Mamgani","year":"2013","unstructured":"Al-Mamgani A, van Rooij P, Mehilal R et al (2013) Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol 270:293\u2013299. https:\/\/doi.org\/10.1007\/s00405-012-2008-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3537_CR44","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/hed.24834","volume":"39","author":"ME Gamez","year":"2017","unstructured":"Gamez ME, Lal D, Halyard MY et al (2017) Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): the mayo clinic experience. Head Neck 39:1819\u20131824. https:\/\/doi.org\/10.1002\/hed.24834","journal-title":"Head Neck"},{"key":"3537_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.amjoto.2003.12.002","volume":"25","author":"BS Kim","year":"2004","unstructured":"Kim BS, Vongtama R, Juillard G (2004) Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol-Head Neck Med Surg 25:162\u2013166. https:\/\/doi.org\/10.1016\/j.amjoto.2003.12.002","journal-title":"Am J Otolaryngol-Head Neck Med Surg"},{"key":"3537_CR46","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.amjoto.2010.09.006","volume":"32","author":"PC Revenaugh","year":"2011","unstructured":"Revenaugh PC, Seth R, Pavlovich JB et al (2011) Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma. Am J Otolaryngol-Head Neck Med Surg 32:464\u2013469. https:\/\/doi.org\/10.1016\/j.amjoto.2010.09.006","journal-title":"Am J Otolaryngol-Head Neck Med Surg"},{"key":"3537_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ijrobp.2007.06.057","volume":"70","author":"AM Chen","year":"2008","unstructured":"Chen AM, Daly ME, El-Sayed I et al (2008) Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 70:338\u2013343. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.06.057","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03537-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T23:17:16Z","timestamp":1621293436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03537-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03537-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict on interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}